Wire · opportunities
Prediction Markets Are Creating a New Insider Trading Frontier for Biotech and ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 1 September 2026 · Fusion42 review
Prediction market platforms that allow bets on clinical trial outcomes and FDA approvals pose new insider trading risks for biotech and pharmaceutical companies, including private firms. Regulatory scrutiny is increasing, and companies must enhance compliance to address broader insider information exposure beyond traditional employee rings.
This Wire brief sits within Fusion42's coverage of Biotech.
◆ ◆ The Wire takeaway
Your biotech or pharma company can no longer rely on traditional insider trading safeguards focused on executives alone. You must urgently expand compliance to cover contractors, partners, and other trial participants to protect market integrity and prevent regulatory sanctions.
◆ Coverage
1 source · 1 Sep 2026
◆ Related on Wire
◆ Topics